Hey Rad, nice to hear from you
Few burning questions from my end, really appreciate it you are able to ask a few of them.
2 and 5 are the most important.
1. Do we still have a partnership with DXB, their Ph2 trail has concluded and PromarkerD was never mentioned.
2. Part of the $3 placement in November 2019 was to secure the reimbursement code (CPT) for the US, given we are now 12months past and still have not received the CPT code, do you have a timeline on when you expect to receive it?
4. What is the timeline for US regulatory approval?
5. Is the validation study for Giardia still on track to be completed this calendar year?
6. Are we still in partnership with Atturos and has there been any progress with their prostrate cancer test (OCProDx)?
7. Is Omics GlobalSolutions still marketing the test in the Dominican Republic?
Cheers
Eqz
Ann: Notice of Annual General Meeting/Proxy Form, page-7
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $81.22M | |||
| Open | High | Low | Value | Volume |
| 63.0¢ | 63.0¢ | 55.0¢ | $571.7K | 964.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 9013 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |